1. Home
  2. APGE vs SFNC Comparison

APGE vs SFNC Comparison

Compare APGE & SFNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • SFNC
  • Stock Information
  • Founded
  • APGE 2022
  • SFNC 1903
  • Country
  • APGE United States
  • SFNC United States
  • Employees
  • APGE N/A
  • SFNC N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • SFNC Major Banks
  • Sector
  • APGE Health Care
  • SFNC Finance
  • Exchange
  • APGE Nasdaq
  • SFNC Nasdaq
  • Market Cap
  • APGE 2.1B
  • SFNC 2.2B
  • IPO Year
  • APGE 2023
  • SFNC N/A
  • Fundamental
  • Price
  • APGE $33.11
  • SFNC $17.39
  • Analyst Decision
  • APGE Strong Buy
  • SFNC Hold
  • Analyst Count
  • APGE 4
  • SFNC 3
  • Target Price
  • APGE $91.33
  • SFNC $23.33
  • AVG Volume (30 Days)
  • APGE 802.7K
  • SFNC 868.7K
  • Earning Date
  • APGE 05-12-2025
  • SFNC 04-16-2025
  • Dividend Yield
  • APGE N/A
  • SFNC 4.89%
  • EPS Growth
  • APGE N/A
  • SFNC N/A
  • EPS
  • APGE N/A
  • SFNC 1.16
  • Revenue
  • APGE N/A
  • SFNC $726,747,000.00
  • Revenue This Year
  • APGE N/A
  • SFNC $21.32
  • Revenue Next Year
  • APGE $743.14
  • SFNC $7.03
  • P/E Ratio
  • APGE N/A
  • SFNC $14.99
  • Revenue Growth
  • APGE N/A
  • SFNC N/A
  • 52 Week Low
  • APGE $26.20
  • SFNC $16.03
  • 52 Week High
  • APGE $63.50
  • SFNC $25.95
  • Technical
  • Relative Strength Index (RSI)
  • APGE 45.63
  • SFNC 29.12
  • Support Level
  • APGE $31.38
  • SFNC $17.35
  • Resistance Level
  • APGE $34.23
  • SFNC $18.47
  • Average True Range (ATR)
  • APGE 3.28
  • SFNC 0.89
  • MACD
  • APGE -0.18
  • SFNC -0.10
  • Stochastic Oscillator
  • APGE 54.22
  • SFNC 5.25

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About SFNC Simmons First National Corporation

Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. The company's loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.

Share on Social Networks: